Clinical Trials Logo

Clinical Trial Summary

This is an open label, prospective, non-randomised, multi-centre first-in-human evaluation of the Vetex Thrombectomy Device for treatment of acute iliofemoral deep vein thrombosis (DVT)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03489135
Study type Interventional
Source Vetex Medical Ltd.
Contact
Status Completed
Phase N/A
Start date November 13, 2018
Completion date May 7, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03575364 - ClotTriever Outcomes (CLOUT) Registry
Terminated NCT04103112 - Compression Hosiery to Avoid Post-Thrombotic Syndrome N/A
Recruiting NCT04833764 - Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis Phase 1/Phase 2
Terminated NCT01647620 - A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses. Phase 1
Completed NCT01347203 - A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting Phase 1
Recruiting NCT03532165 - Use of Bedside Ultrasound in Emergency Department Patients With Concern for Pulmonary Embolism to Reduce CT Imaging N/A